交易中 09-20 12:52:02 美东时间
+0.120
+4.24%
Cyclerion Therapeutics (NASDAQ:CYCN) reported quarterly losses of $(0.53) per share. This is a 71.04 percent increase over losses of $(1.83) per share from the same period last year.
08-27 21:58
Cyclerion Therapeutics (NASDAQ:CYCN) said it has appointed Regina Graul as CEO and president. Graul had joined the company as president in early December last year. More on Cyclerion Therapeutics Fina...
08-07 20:16
Cyclerion Therapeutics: Regina Graul Promoted to CEO, President
08-07 19:17
北京时间2024年01月26日22时39分,Alector Inc(ALEC.us)股票出现异动,股价快速拉升5.44%。截至发稿,该股报6.40美元/股,成交...
01-26 22:39
Gainers Inovio Pharmaceuticals (NASDAQ:INO) shares moved upwards by 33.2% to $...
2023-10-11 01:31
Wednesday saw 59 companies set new 52-week lows.
2023-07-27 00:18
Cyclerion's stock will continue to be listed and traded on the Nasdaq Capital Market.
2023-06-02 04:01
Cyclerion Therapeutics Inc (NASDAQ: CYCN) has agreed to sell two of its assets - zagociguat (formerly CY6463) and CY3018, to a new private company ("NewCo") formed by certain current Cyclerion shareholders and new investors who have agreed to
2023-05-13 00:59
Net loss was approximately $(7.0) million for Q1 2023, as compared to approximately $(13.0) million for Q1 2022.
2023-05-12 06:07
Certain Cyclerion shareholders and new investors have agreed to invest $81M to launch a new company targeting diseases of mitochondrial dysfunction. Cyclerion will receive $8 million in cash
2023-05-12 06:03